To date, several reports have shown an important role for IL-23 and its pathogenic mediators in murine models of rheumatoid arthritis, psoriasis, spondyloarthropathy, and inflammatory bowel diseases [10] (Figure 1). Here, IL37 is linked to inflammatory bowel disease.